EN | RU
EN | RU

Help Support

How much time do you have? in mins

Newly Added

Read
Watch
  • 2 min

    Diet rich in polyunsaturated fatty acid, protein a...

    Based on the 1-year outcomes of the NutriAct Trial, the intake of a diet comprising of high polyunsaturated fatty acid (PUFA), protein and fibres...

    More details
  • 3 min

    Labetalol found safer and more tolerable than Nife...

    Even though Labetalol and Nifedipine were found to be equally effective in Preeclampsia, however, Labetalol outshined Nifedipine i...

    More details
  • 3 min

    Medically supervised prolonged fasting boosts pati...

    The outcomes of an observational study published in the ‘Nutrients’ journal established prolonged therapeutic fasting intervention al...

    More details
  • 3 min

    FDA nods for Resmetirom, first-of-its-kind liver s...

    Resmetirom is now FDA-approved for non-cirrhotic non-alcoholic steatohepatitis (NASH) with moderate to advanced liver scarring (fibrosi...

    More details
  • 3 min

    Dupilumab shows unprecedented success in treating...

    In a retrospective study comprising of patients with hand eczema, Dupilumab demonstrated unparalleled efficacy and superior safety profile across...

    More details

Categories

News
Science
Drugs
Events
Education
AvRooms
News See All
25

Diet rich in polyunsaturated fatty acid, protein a...

2 min Medical News

Based on the 1-year outcomes of the NutriAct Trial, the intake of a diet comprising of high polyunsaturated fatty acid (PUFA), protein and fibres...

  • 3 min

    Labetalol found safer and more tolerable than Nife...

    Even though Labetalol and Nifedipine were found to be equally effective in Preeclampsia, however, Labetalol outshined Nifedipine i...

    More details
  • 3 min

    Medically supervised prolonged fasting boosts pati...

    The outcomes of an observational study published in the ‘Nutrients’ journal established prolonged therapeutic fasting intervention al...

    More details
  • 3 min

    FDA nods for Resmetirom, first-of-its-kind liver s...

    Resmetirom is now FDA-approved for non-cirrhotic non-alcoholic steatohepatitis (NASH) with moderate to advanced liver scarring (fibrosi...

    More details
  • 3 min

    Dupilumab shows unprecedented success in treating...

    In a retrospective study comprising of patients with hand eczema, Dupilumab demonstrated unparalleled efficacy and superior safety profile across...

    More details
  • 2 min

    Vonoprazan-Amoxicillin duo with S. boulardii effec...

    Adjunct therapy of Saccharomyces boulardii (S. boulardii) along with Vonoprazan-amoxicillin dual therapy offers new hope for Helicobact...

    More details
  • 2 min

    Can Esketamine injection prevent cough induced due...

    According to a recent study published in the ‘BMC Anesthesiology’ journal, pretreatment with intravenous administration of...

    More details
  • 2 min

    Delphi Consensus: Brivaracetam as first add-on the...

    Picking the best of the best! Brivaracetam, a third-generation anti-seizure medication, has emerged as a potential early add-on therapy for...

    More details
  • 2 min

    Boons of Facilitated Telemedicine for hepatitis C,...

    Performed across New York State, a novel clinical study found that integrating facilitated telemedicine into opioid treatment programs significan...

    More details
  • 2 min

    Minimally-invasive innovative interspinous device...

    Conducted across 3 medical centres, an innovative percutaneous interspinous device (PID) promises remarkable relief for patients suffer...

    More details
Try: